Signals Blog
Menu

Explaining the hype: CAR T-cells

With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...

Right Turn: Singing his way to (science) fame

Happy Thanksgiving to our American family, friends and colleagues. It may feel like 2017 didn’t offer quite as much to be thankful for on a global level, but there was one uplifting international event that rocked our world. Despacito. On January 12, 2017, Universal...